Properties of recombinant interleukin 2-cultured tumor-infiltrating lymphocytes in human lung cancer
- 15 April 1989
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 43 (4) , 619-623
- https://doi.org/10.1002/ijc.2910430414
Abstract
It is thought that TIL can be activated in vitro by rIL‐2 and acquire specific anti‐tumor activity. In this study, we investigated this possibility, using lymphocytes isolated from primary lung cancer tissues. In a first series of experiments, TILs and autologous PBLs from 16 patients were cultured in rIL‐2 from 7 to 14 days under identical conditions, and were compared for proliferation (16 cases), cytolytic activity (11 cases), gamma interferon (IFN‐γ) production (8 cases), and phenotypes (10 cases). TILs grew in response to rIL‐2 as well as PBLs. However, the induced cytolytic activity of TIL was significantly lower than that of PBL against autologous tumor cells and 2 human tumor cell lines. IL‐2‐mediated IFN‐γ production by TILs was also significantly lower than that of PBLs. TILs were phenotypically characterized by their high CD4/CD8 ratio and lack of Leu 11‐positive cells. Further investigations with 7 other cases showed that exogenous addition of IFN‐γ to rIL‐2 cultures of TILs enhanced cytolytic activity in 4 cases. Our results indicate that IL‐2 alone is sufficient for TILs to proliferate but not to acquire new functions (cytotoxicity and production of IFN‐γ).This publication has 22 references indexed in Scilit:
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating LymphocytesScience, 1986
- Purification and characterization of recombinant human interleukin-2 produced in Escherichia coliBiochemical and Biophysical Research Communications, 1985
- Response of resting human peripheral blood natural killer cells to interleukin 2.The Journal of Experimental Medicine, 1984
- Use of monoclonal antibodies as sensitive and specific probes for biologically active human gamma-interferon.Proceedings of the National Academy of Sciences, 1984
- Interleukin 2-mediated immune interferon (IFN-gamma) production by human T cells and T cell subsets.The Journal of Immunology, 1983
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Regulation of the production of immune interferon and cytotoxic T lymphocytes by interleukin 2.The Journal of Immunology, 1981
- Cytological and functional analysis of inflammatory infiltrates in human malignant tumorsCellular Immunology, 1980
- Suppressor cell activity of lymphocytes infiltrating human lung and breast tumoursInternational Journal of Cancer, 1979